REPLICEL LIFE SCIENCES INC. Quotes RepliCel Life Sciences Inc. Toronto S.E.
Equities
RP
CA76027P4006
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.055 CAD | -.--% |
|
-21.43% | -15.38% |
Performance
| 6 months | -45.00% | ||
| Current year | -15.38% | ||
| 1 year | -78.00% | ||
| 3 years | -84.72% | ||
| 5 years | -84.29% | ||
| 10 years | -99.11% |
Volumes
marketsDaily volume
0
Estimated daily volume
0
Avg. Volume 20 sessions
24 966
Daily volume ratio
0.00
Avg. Volume 20 sessions CAD
1 373.13
Avg. Volume 20 sessions USD
998.00
Record volume 1
1 301 647
Record volume 2
1 165 052
Record volume 3
832 602
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (CAD)
3 830 906
Capitalization (USD)
2 784 341
Net sales (CAD)
353 735
Net sales (USD)
257 098
Number of employees
1
Sales / Employee (CAD)
353 735
Sales / Employee (USD)
257 098
Free-Float
39.48 %
Free-Float capitalization (CAD)
1 429 181
Free-Float capitalization (USD)
1 038 743
Average Daily Capital Traded
0.04%
Highs and lows
Current year
0.05
0.07
1 year
0.040.25
3 years
0.040.42
5 years
0.000.58
10 years
0.007.20
Indicators
Moving average 5 days
0.06
Moving average 20 days
0.06
Moving average 50 days
0.08
Moving average 100 days
0.13
Price spread / (MMA5)
+9.09%
Price spread / (MMA20)
+9.09%
Price spread / (MMA50)
+45.45%
Price spread / (MMA100)
+136.36%
STIM
RSI 9 days
45.42
RSI 14 days
45.21
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -.--% | -21.43% | -15.38% | -78.00% | 2.78M | ||
| -0.51% | +6.08% | +18.72% | +48.79% | 125B | ||
| +0.22% | +2.33% | +14.19% | +35.79% | 108B | ||
| -1.44% | -0.26% | -4.93% | -8.29% | 24.57B | ||
| +0.51% | +4.08% | +3.23% | -3.95% | 22.82B | ||
| -0.54% | -0.36% | -10.44% | -28.25% | 18.19B | ||
| -0.45% | +1.07% | -41.74% | -34.23% | 16.54B | ||
| -0.79% | +5.05% | -13.31% | -30.32% | 16.5B | ||
| +1.43% | -0.32% | +2.44% | +44.82% | 13.39B | ||
| +5.01% | -5.04% | +27.89% | -3.58% | 11.1B | ||
| -0.56% | +3.27% | +83.45% | +187.41% | 9.22B | ||
| -2.13% | +13.90% | -24.26% | -33.18% | 8.49B | ||
| -0.96% | +1.53% | +8.91% | +51.74% | 7.94B | ||
| -2.12% | +1.00% | +13.01% | +38.48% | 7.89B | ||
| -0.60% | -1.77% | -5.61% | +22.76% | 7.34B | ||
| -1.15% | +14.81% | +37.58% | +46.46% | 6.55B | ||
| Average | -0.21% | +3.02% | +5.86% | +16.03% | ||
| Weighted average by Cap. | +0.05% | +4.69% | +9.94% | +27.97% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -15.38% | ||
| 2023 | -23.53% | ||
| 2022 | -63.04% | ||
| 2021 | -.--% | ||
| 2020 | -9.80% | ||
| 2019 | -31.08% | ||
| 2018 | -7.50% | ||
| 2017 | -57.89% | ||
| 2016 | -62.75% | ||
| 2015 | -31.08% | ||
| 2014 | -56.47% |
- Stock Market
- Equities
- REPCF Stock
- RP Stock
- Quotes RepliCel Life Sciences Inc.